Nevertheless, 87 per cent of the analysts tracking the stock have a buy recommendation. Torrent Pharma, trading at valuations richer than Sun Pharma, is another company with encouraging prospects. Its acquisition of Unichem Labs in the domestic market, and growing business in the US, Germany and Brazil, burnish its allure. Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding SUN PHARMACEUTICAL is 'Not Rated'.Macroaxis provides SUN PHARMACEUTICAL buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SUNPHARMA positions.

Sun Pharma is India’s top drug maker and world’s fifth largest specialty generic pharmaceutical company by revenue with 41 manufacturing facilities spread across 6 continents. Focus on developing and commercializing innovative specialty products coupled with cost control measures in the generics business is the key priority for them. Only 40 per cent of the analysts tracking Sun Pharma’s stock have a buy recommendation on it. Given these circumstances, investors would want the company to disclose more — be it the price paid to settle the US antitrust litigation related to Modafinil drug, or the progress on approvals from its Halol plant, or any related party Sun Pharma Q4: Profit down 52.6 percent at Rs 635.9 crore versus Rs 1,342.5 crore; revenue up 2.7 percent at Rs 7,163.9 crore versus Rs 6,977 crore (YoY). Company absorbed unsold goods worth Rs Get latest Sun Pharma News/Updates and Results/Analysis. Also get Sun Pharma Share/Stock detailed Information on Sun Pharma along with top stories and articles on Sun Pharma during last 6 months. Sun Pharma share price rises 10% as board to consider share buyback. Mar 12, 22:36. Sun Pharma board to consider share buyback plan next week. Mar 09, 21:09. Pharma sales see rebound in February on back of respiratory drugs. Mar 04, 13:03. Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

SUN PHARMA: Get the latest SUN PHARMA Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com

Sun Pharmaceutical Industries Ltd is an international specialty pharma company. The company also makes active pharmaceutical ingredients. In branded markets, their products are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, dialectology and respiratory. SUN PHARMA: Get the latest SUN PHARMA Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/NSE, F&O Quote of Sun Pharmaceutical Industries Stock has jumped by more than 10% in last two weeks from its lowest level of 325.0 dt 13-Mar-20: Share has hit 52 Week high on 13-Mar-20 (Yesterday). Stock has fallen by more than 10% in last two weeks from its highest level of 414.8 dt 05-Mar-20. Stock has fallen by more than 25% in last three Month from its highest level of 462.5 dt 28-Jan-20. Nevertheless, 87 per cent of the analysts tracking the stock have a buy recommendation. Torrent Pharma, trading at valuations richer than Sun Pharma, is another company with encouraging prospects. Its acquisition of Unichem Labs in the domestic market, and growing business in the US, Germany and Brazil, burnish its allure.

Sun Pharmaceutical Industries Ltd is an international specialty pharma company. The company also makes active pharmaceutical ingredients. In branded markets, their products are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, dialectology and respiratory.

Sun Pharma Inds. Analyst, Brokerage Reports, Latest Research Report on Sun Pharma Inds.. Sun Pharma Inds. Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Sun Pharma Inds., Sun Sun Pharmaceutical Industries Ltd is an international specialty pharma company. The company also makes active pharmaceutical ingredients. In branded markets, their products are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, dialectology and respiratory. SUN PHARMA: Get the latest SUN PHARMA Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/NSE, F&O Quote of Sun Pharmaceutical Industries Stock has jumped by more than 10% in last two weeks from its lowest level of 325.0 dt 13-Mar-20: Share has hit 52 Week high on 13-Mar-20 (Yesterday). Stock has fallen by more than 10% in last two weeks from its highest level of 414.8 dt 05-Mar-20. Stock has fallen by more than 25% in last three Month from its highest level of 462.5 dt 28-Jan-20. Nevertheless, 87 per cent of the analysts tracking the stock have a buy recommendation. Torrent Pharma, trading at valuations richer than Sun Pharma, is another company with encouraging prospects. Its acquisition of Unichem Labs in the domestic market, and growing business in the US, Germany and Brazil, burnish its allure.

8 Nov 2019 Sun Pharma's net sales for the quarter rose 16.10 per cent to Rs our BUY recommendation on the stock with a Target Price of Rs 500, 

2 Dec 2019 Shrikant Chouhan recommended to keep a stoploss at Rs 438 . Whenever the stock has seen such a formation, the analyst said it can be  8 Nov 2019 Sun Pharma's net sales for the quarter rose 16.10 per cent to Rs our BUY recommendation on the stock with a Target Price of Rs 500,  11 Jun 2019 Meanwhile, HDFC Securities is bullish on Sun Pharma has recommended a 'buy' rating on the stock with a target price of Rs 600 in its research  Industries Limited - SUNPHARMA Important levels,Technical Analysis,Future & Option,Interactive Charts,Short & Long term Stock Recommendation @ 682.55  Sun Pharmaceuticals Industries Limited. Stock Code: NSE » SUNPHARMA AND BSE » 524715. 362.75 -7.4 (-1.9%). Details, Technicals for, 19-03-2020. Check out the latest announcements & notices related to dividend, stock splits, 28-05-2019, Dividend inter alia, To consider recommendation of dividend for the Gufic Pharma Limited and Sun Pharma Medisales Private Limited (formerly 

Sun Pharmaceutical Industries Ltd (SUNPHARMA) Stock Market info. Recommendations: Buy or sell Sun Pharmaceutical Industries stock? Mumbai Stock Market 

14 Aug 2019 Sun Pharma shares fall 7% post Q1 earnings, brokerages turn mixed on has a ' hold' recommendation with a target price of Rs 400 per share. 15 Jul 2019 The global brokerage firm said Sun Pharma was its top pick in its Indian healthcare coverage and sees 27 per cent upside potential in the stock. Share Price Live - 368.55, Sun Pharma. Stock Price, Today - The Economic Times. Sun Pharma. Share Price Live - 368.55, Sun Pharma. Stock Price, Today - The Economic Times Never miss a great news story! Views and Recommendations Technical Charts Portfolio ET 500 Companies Quarterly Results (Earnings) Trending in Markets. SBI Share Price We analyse every Sun Pharma Inds. stock recommendation and show you their performance. Get Sun Pharma Inds. detailed broker calls screener with many filters. Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding SUN PHARMACEUTICAL is 'Not Rated'.Macroaxis provides SUN PHARMACEUTICAL buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SUNPHARMA positions.

Sun Pharma Advanced Research Company Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 2743.64 Crore) operating in Pharmaceuticals sector. Sun Pharma Advanced Research Company Ltd. key Products/Revenue Segments include Sale of services which contributed Rs 182.87 Crore to Sales Value (100.00 % of Total Sales Historical index on Bombay Stock Exchange : D "Should I invest in Sun Pharmaceutical Industries stock?" "Should I trade "SUNPHARMA" stock today?" According to our live Forecast System, Sun Pharmaceutical Industries Ltd stock is a bad long-term (1-year) investment*. "Sun Pharmaceutical Industries Ltd" stock predictions are updated every 5 minutes with latest exchange prices by smart technical Get Live Sun Pharmaceutical Industries stock market chart. Free Sun Pharma Historic stock charts for NSE / BSE. Get Sun Pharmaceutical Industries detailed stock quotes and technical charts for Sun